Investment
Features
FeesSafety
Academy
More
Pluang+

Questor reports 2025 revenue growth driven by international sales despite Q4 challenges and posts improved adjusted EBITDA.

Company Fundamentals
21 Apr 2026
GlobeNewsWire
View Source
Bearish
pluang ai news

Questor Technology Inc. announced its 2025 financial results showing annual revenue growth to $6.8 million from $4.5 million in 2024, driven by increased international equipment sales aligned with its global diversification strategy. However, Q4 revenue declined to $0.7 million from $1.8 million due to longer sales cycles and low rental unit utilization in the U.S. Adjusted EBITDA improved to a negative $0.3 million for the year, reflecting better margins and cost management, despite a Q4 decline. The company highlighted ongoing demand for its methane reduction technology amid tightening global regulations, with key contracts in the Middle East, Mexico, and Canada, and plans to demonstrate a waste-heat-to-power prototype in 2026. Questor remains debt-free and strategically positioned for growth in emissions reduction markets.

More News

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...

Others
Neutral
1 hour ago
ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...

Others
Bullish
2 hours ago
Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...

Company Fundamentals
Bullish
3 hours ago
Goldman Sachs posts strong Q2 FY2026 with 38% earnings growth and $31B raised in private credit.

Goldman Sachs posts strong Q2 FY2026 with 38% earnings growth and $31B raised in private credit.

Goldman Sachs reported robust Q2 FY2026 results, with net earnings growing at an annualized rate of 38%. The firm raised $31 billion in private credit and saw a 130% year-over-year surge in equity underwriting revenues, driven by major deals and IPO ...

Company Fundamentals
Bullish
4 hours ago
Bitwise Bitcoin ETF offers low fees but struggles with market share and advisor adoption.

Bitwise Bitcoin ETF offers low fees but struggles with market share and advisor adoption.

The Bitwise Bitcoin ETF (BITB) features competitive fees and tight trading spreads comparable to industry leaders like IBIT and FBTC. Despite strong execution on cost and trading efficiency, BITB's market share and asset growth have stalled due to li...

Analyst Insights
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App